News

News2018-07-03T13:29:18+00:00

Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network

November 20th, 2018|

-- Conference Call at 8:30 a.m. ET Today -- East Rutherford, NJ – November 20, 2018 – Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and Read More